These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12794215)

  • 1. Vulvovaginal carriage of yeasts other than Candida albicans.
    Holland J; Young ML; Lee O; C-A Chen S
    Sex Transm Infect; 2003 Jun; 79(3):249-50. PubMed ID: 12794215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and antifungal susceptibility of vaginal yeasts in outpatients attending a gynecological center in Ancona, Italy.
    Arzeni D; Del Poeta M; Simonetti O; Offidani AM; Lamura L; Balducci M; Cester N; Giacometti A; Scalise G
    Eur J Epidemiol; 1997 Jun; 13(4):447-50. PubMed ID: 9258552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and antifungal susceptibility of Candida albicans and its related species Candida dubliniensis and Candida africana isolated from vulvovaginal samples in a hospital of Argentina.
    Theill L; Dudiuk C; Morano S; Gamarra S; Nardin ME; Méndez E; Garcia-Effron G
    Rev Argent Microbiol; 2016; 48(1):43-9. PubMed ID: 26922471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of Farnesol with Common Antifungal Drugs: Inhibitory Effect against
    Nikoomanesh F; Falahatinejad M; Černáková L; Dos Santos ALS; Mohammadi SR; Rafiee M; Rodrigues CF; Roudbary M
    Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109701
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).
    Zida A; Yacouba A; Bamba S; Sangare I; Sawadogo M; Guiguemde T; Kone S; Traore LK; Ouedraogo-Traore R; Guiguemde RT
    J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use].
    Saporiti AM; Gómez D; Levalle S; Galeano M; Davel G; Vivot W; Rodero L
    Rev Argent Microbiol; 2001; 33(4):217-22. PubMed ID: 11833253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Species spectrum and antifungal susceptibility profile of vaginal isolates of Candida in Kuwait.
    Alfouzan W; Dhar R; Ashkanani H; Gupta M; Rachel C; Khan ZU
    J Mycol Med; 2015 Mar; 25(1):23-8. PubMed ID: 25534676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Susceptibility of yeasts to antifungal agents in Kaunas University of Medicine Hospital].
    Skrodeniene E; Dambrauskiene A; Vitkauskiene A
    Medicina (Kaunas); 2006; 42(4):294-9. PubMed ID: 16687901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo activity of tea tree oil against azole-susceptible and -resistant human pathogenic yeasts.
    Mondello F; De Bernardis F; Girolamo A; Salvatore G; Cassone A
    J Antimicrob Chemother; 2003 May; 51(5):1223-9. PubMed ID: 12668571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular typing and in vitro fluconazole susceptibility of Candida species isolated from diabetic and nondiabetic women with vulvovaginal candidiasis in India.
    Lattif AA; Mukhopadhyay G; Banerjee U; Goswami R; Prasad R
    J Microbiol Immunol Infect; 2011 Jun; 44(3):166-71. PubMed ID: 21524609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
    Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
    Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Species distribution and susceptibility of Candida isolates from patient with vulvovaginal candidiasis in Southern China from 2003 to 2012.
    Liu XP; Fan SR; Peng YT; Zhang HP
    J Mycol Med; 2014 Jun; 24(2):106-11. PubMed ID: 24746725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Candida albicans, Candida dubliniensis and Candida africana in pregnant women suffering from vulvovaginal candidiasis in Argentina.
    Mucci MJ; Cuestas ML; Landanburu MF; Mujica MT
    Rev Iberoam Micol; 2017; 34(2):72-76. PubMed ID: 28385421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yeasts isolated from nosocomial urinary infections: antifungal susceptibility and biofilm production.
    de Freitas AR; Baeza LC; Faria MG; Dota KF; Godoy Martínez P; Svidzinski TI
    Rev Iberoam Micol; 2014; 31(2):104-8. PubMed ID: 23810785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
    Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A;
    J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and antifungal susceptibility of Candida species among pregnant women attending a school maternity at Natal, Brazil.
    Brandão LDS; Boniek D; Resende Stoianoff MA; da Mata FMR; de Azevedo PRM; Fernandes JV; Andrade VS
    Lett Appl Microbiol; 2018 Sep; 67(3):285-291. PubMed ID: 29908032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
    Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
    Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence of vaginal candidiasis in pregnant women. Identification of yeasts and susceptibility to antifungal agents].
    García Heredia M; García SD; Copolillo EF; Cora Eliseth M; Barata AD; Vay CA; de Torres RA; Tiraboschi N; Famiglietti AM
    Rev Argent Microbiol; 2006; 38(1):9-12. PubMed ID: 16784126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.